HERIBERTO PRADO GARCIA



DATOS GENERALES
Nombre completo   HERIBERTO PRADO GARCIA
Máximo nivel de estudios   DOCTORADO
Antigüedad académica en la UNAM   9 años
NOMBRAMIENTOS
Vigente   PROFESOR ASIGNATURA B TP No Definitivo
Facultad de Ciencias
Desde 16-10-2024
PROFESOR ASIGNATURA B TP No Definitivo
Facultad de Ciencias
Desde 01-10-2023 hasta 15-10-2024
PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Ciencias
Desde 01-12-2017 hasta 30-09-2023
PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Ciencias
Desde 01-11-2016 hasta 30-11-2017
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI II2020 - VIGENTE
* SNI I2013 - 2019
* SNI I2010 - 2011

INFORMACIÓN DE PUBLICACIONES
Firmas  
Heriberto P.-G. Prado García H. Prado-García H. PradoGarcia, H Prado-Garcia, H Prado-Garcia, Heriberto
ID's SCOPUS  
6506249436
ORCID's  
0000-0002-4932-3244
Áreas de conocimiento  
Biochemistry and molecular biology Biotechnology and applied microbiology Chemistry, multidisciplinary Chemistry, organic Endocrinology and metabolism
Engineering, chemical Genetics and heredity Immunology Jcs 2008 Medicine, general & internal
Medicine, general and internal Oncology Pharmacology and pharmacy Public, environmental and occupational health Respiratory system
Scie jcr Surgery Biochemistry Biotechnology Clinical biochemistry
Chemical engineering (miscellaneous) Chemistry (miscellaneous) Genetics Health, toxicology and mutagenesis Immunology and Allergy
Materials chemistry Medicine (miscellaneous) Oncology Organic chemistry Pharmacology
Pulmonary and Respiratory Medicine Spectroscopy Surgery
Coautorías con entidades de la UNAM  
  • Consejo Técnico y Coordinación de la Investigación Científica
  • Centro de Física Aplicada y Tecnología Avanzada
  • Instituto de Investigaciones Biomédicas
  • Instituto de Química
  • Instituto de Biotecnología
  • Facultad de Ciencias
  • Facultad de Medicina
  • Facultad de Química
  • Dirección General de Asuntos del Personal Académico
Revistas en las que ha publicado  (31):
  1. AMERICAN JOURNAL OF CANCER RESEARCH, Estados Unidos America (2020, 2021)
  2. ANN THORAC SURG, Estados Unidos America (2014)
  3. ANTICANCER RESEARCH, Grecia (2015)
  4. BIOMED RESEARCH INTERNATIONAL, Estados Unidos America (2015)
  5. BIOMEDICINE & PHARMACOTHERAPY, Francia (2020)
  6. Bmc Cancer, Reino Unido (2015)
  7. CANCER BIOLOGY & THERAPY, Estados Unidos America (2011)
  8. CANCER IMMUNOLOGY IMMUNOTHERAPY, Estados Unidos America (2006, 2008, 2012, 2017)
  9. Cancers, Suiza (2019)
  10. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, Estados Unidos America (2012)
  11. CLINICAL IMMUNOLOGY, Estados Unidos America (2007)
  12. CHEMICAL BIOLOGY & DRUG DESIGN, Estados Unidos America (2024)
  13. EXPERIMENTAL LUNG RESEARCH, Estados Unidos America (2014)
  14. Forum on Immunopathological Diseases and Therapeutics, Estados Unidos America (2021)
  15. Frontiers in Genetics, Suiza (2022, 2023)
  16. FRONTIERS IN IMMUNOLOGY, Suiza (2016)
  17. Frontiers in Oncology, Suiza (2019, 2020)
  18. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Suiza (2022)
  19. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Suiza (2023, 2024)
  20. INTERNATIONAL JOURNAL OF ONCOLOGY, Grecia (2019)
  21. JOURNAL OF IMMUNOLOGY RESEARCH, Estados Unidos America (2016, 2021)
  22. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, Reino Unido (2015, 2021, 2025)
  23. LUNG CANCER, Irlanda (2002, 2004, 2005)
  24. Metabolites, Suiza (2024)
  25. NEW JOURNAL OF CHEMISTRY, Reino Unido (2023)
  26. PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, Reino Unido (2021)
  27. Processes, Suiza (2021)
  28. Results In Chemistry, Países Bajos (2025)
  29. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, México (2004, 2012, 2019)
  30. Revista Del Instituto Nacional De Enfermedades Respiratorias, México (2000, 2002)
  31. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, Estados Unidos America (2019)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Novel N-quaternary coumarin-3-yl-imidazo[1,2-a]pyridines as fluorescent hybrids: Their synthesis and biological evaluation in cancer cellsCoautor: Prado-Garcia H., Armendariz-Barrientos K., Pérez L.A., Lagunas-Rivera S., et al.2025Results In ChemistryWoS-id: 001389691700001
Scopus-id: 2-s2.0-85212104443
22
2GPER1 activation by estrogenic compounds in the inflammatory profile of breast cancer cellsCoautor: Heriberto P.-G., Mariana S.-M., Brenda R.-P., Cristina L., et al.2025JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGYWoS-id: 001448281300001
Scopus-id: 2-s2.0-85209590304
00
3Metabolic Responses of Lung Adenocarcinoma Cells to Survive under Stressful Conditions Associated with Tumor MicroenvironmentCoautor y autor de correspondencia: Prado-Garcia H., Carlos-Reyes A., Romero-Garcia S.2024MetabolitesWoS-id: 001175130300001
Scopus-id: 2-s2.0-85185689958
33
4Evaluation of doxorubicin and ß-lapachone analogs as anticancer agents, a biological and computational studyCoautor: Prado-Garcia, H, Mercado-Sánchez, I, López, J, Chávez-Rocha, R, et al.2024CHEMICAL BIOLOGY & DRUG DESIGNWoS-id: 001275832800001
Scopus-id: 2-s2.0-85199580110
22
5Intratumoral Heterogeneity and Metabolic Cross-Feeding in a Three-Dimensional Breast Cancer Culture: An In Silico PerspectiveCoautor: Prado-García H., Arellano-Villavicencio J.E., Vázquez-Jiménez A., Oropeza-Valdez J.J., et al.2024INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESWoS-id: 001341678900001
Scopus-id: 2-s2.0-85207425250
00
6Editorial: Molecular basis of epigenetic regulation in cancer therapiesCoautor: Prado-Garcia, Heriberto, Carlos-Reyes, Angeles, Romero-Garcia, Susana, Lopez-Camarillo, Cesar, et al.2023Frontiers in GeneticsWoS-id: 000921860800001
Scopus-id: 2-s2.0-85147017760
00
7A rollover Ir(iii) complex of 2-(6-bromopyridin-2-yl)imidazo[1,2-a]pyridineCoautor: Prado-Garcia H., Varela Y., Ramírez-García G., Jimenez-Halla J.O.C., et al.2023NEW JOURNAL OF CHEMISTRYWoS-id: 000932324000001
Scopus-id: 2-s2.0-85147165323
33
8The Phytochemical a-Mangostin Inhibits Cervical Cancer Cell Proliferation and Tumor Growth by Downregulating E6/E7-HPV Oncogenes and KCNH1 Gene ExpressionCoautor: Prado-Garcia, Heriberto, Diaz, Lorenza, Bernadez-Vallejo, Samantha V., Vargas-Castro, Rafael, et al.2023INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESWoS-id: 000932820900001
Scopus-id: 2-s2.0-85147894253
1921
9Role of Circular RNAs in the Regulation of Immune Cells in Response to Cancer TherapiesCoautor: Prado-Garcia, Heriberto, Carlos-Reyes, Angeles, Romero-Garcia, Susana, Contreras-Sanzon, Estefania, et al.2022Frontiers in GeneticsWoS-id: 000759466300001
Scopus-id: 2-s2.0-85124879360
1112
10The Interplay of GPER1 with 17 beta-Aminoestrogens in the Regulation of the Proliferation of Cervical and Breast Cancer Cells: A Pharmacological ApproachCoautor: Prado-Garcia, Heriberto, Segovia-Mendoza, Mariana, Mirzaei, Elahe, Miranda, Luis D., et al.2022INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTHWoS-id: 000866849600001
Scopus-id: 2-s2.0-85139812571
35
11Histone deacetylases modulate resistance to the therapy in lung cancer2ᵒ autor: Prado-Garcia, Heriberto, Contreras-Sanzon, Estefania, Romero-Garcia, Susana, Nuñez-Corona D., et al.2022Frontiers in GeneticsWoS-id: 000892152400001
Scopus-id: 2-s2.0-85139972050
1918
12Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition ActivationCoautor: Prado-Garcia, Heriberto, Segovia-Mendoza, Mariana, Romero-Garcia, Susana, Lemini, Cristina2021JOURNAL OF IMMUNOLOGY RESEARCHWoS-id: 000611571900001
Scopus-id: 2-s2.0-85099650744
1110
13Obtaining symmetric and asymmetric bisphosphoramidates and bisphosphoramidothioates by a single step multicomponent reactionCoautor: Prado-Garcia, Heriberto, Zamudio-Medina, Angel, Perez-Hernandez, Nury, Castrejon-Flores, Jose Luis, et al.2021PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTSWoS-id: 000614187200001
Scopus-id: 2-s2.0-85100571929
12
14a-Mangostin Synergizes the Antineoplastic Effects of 5-Fluorouracil Allowing a Significant Dose Reduction in Breast Cancer CellsCoautor: Prado-Garcia H., Lara-Sotelo G., Díaz L., García-Becerra R., et al.2021ProcessesWoS-id: 000634163300001
Scopus-id: 2-s2.0-85102765028
44
15Antitumoral effects of dovitinib in triple-negative breast cancer are synergized by calcitriol in vivo and in vitroCoautor: Prado-Garcia, Heriberto, Garcia-Quiroz, Janice, Cardenas-Ochoa, Nohemi, Garcia-Becerra, Rocio, et al.2021JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGYWoS-id: 000703194900005
Scopus-id: 2-s2.0-85113470073
810
16Calcitriol induces estrogen receptor alpha expression through direct transcriptional regulation and epigenetic modifications in estrogen receptor-negative breast cancer cellsCoautor: Prado-Garcia, Heriberto, Santos-Martinez, Nancy, Diaz, Lorenza, Ortiz-Ortega, Victor M., et al.2021AMERICAN JOURNAL OF CANCER RESEARCHWoS-id: 000738351400012
100
17A Brief Review on the Metabolic Evasion Mechanisms of Tumor Cells against T CellsCoautor y autor de correspondencia: Prado-Garcia H., Romero-Garcia S., Carlos-Reyes A.2021Forum on Immunopathological Diseases and TherapeuticsScopus-id: 2-s2.0-85127875340
00
18IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine modelCoautor: Prado-García H., Santana-Krímskaya S.E., Franco-Molina M.A., Zárate-Triviño D.G., et al.2020BIOMEDICINE & PHARMACOTHERAPYWoS-id: 000526785500036
Scopus-id: 2-s2.0-85081227489
2125
19Role of DNA Methylation in the Resistance to Therapy in Solid Tumors2ᵒ autor: Prado-Garcia H., Romero-Garcia S., Carlos-Reyes A.2020Frontiers in OncologyWoS-id: 000563459400001
Scopus-id: 2-s2.0-85089840421
98104
20An organotin indomethacin derivative inhibits cancer cell proliferation and synergizes the antiproliferative effects of lapatinib in breast cancer cellsCoautor: Prado-Garcia, Heriberto, Segovia-Mendoza, Mariana, Camacho-Camacho, Carlos, Rojas-Oviedo, Irma, et al.2020AMERICAN JOURNAL OF CANCER RESEARCHWoS-id: 000583897900018
60
21Lactic Acidosis in the Presence of Glucose Diminishes Warburg Effect in Lung Adenocarcinoma Cells1ᵉʳ autor: Prado-Garcia H., Campa-Higareda A., Romero-Garcia S.2020Frontiers in OncologyScopus-id: 2-s2.0-85087024679
015
22Mitochondrial calcium: Transport and modulation of cellular processes in homeostasis and cancer (Review)2ᵒ autor y autor de correspondencia: Prado-Garcia H., Romero-Garcia S.2019INTERNATIONAL JOURNAL OF ONCOLOGYWoS-id: 000461097600002
Scopus-id: 2-s2.0-85062646686
119126
23ASTEMIZOLE, AN INHIBITOR OF ETHER-À-GO-GO-1 POTASSIUM CHANNEL, INCREASES THE ACTIVITY OF THE TYROSINE KINASE INHIBITOR GEFITINIB IN BREAST CANCER CELLSCoautor: Prado-García H., García-Quiroz J., González-González M.E., Díaz L., et al.2019REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000476468900005
Scopus-id: 2-s2.0-85067821579
1617
24Deficient glucose uptake is linked to impaired Glut1 expression upon CD3/CD28 stimulation in memory T cells from pleural effusions secondary to lung cancer1ᵉʳ autor: Prado-Garcia H., Romero-Garcia S., Castro-Flores D.A., Rumbo-Nava U.2019SCANDINAVIAN JOURNAL OF IMMUNOLOGYWoS-id: 000477185400001
Scopus-id: 2-s2.0-85069838832
45
25Lactic acidosis promotes mitochondrial biogenesis in lung adenocarcinoma cells, supporting proliferation under normoxia or survival under hypoxia2ᵒ autor: Prado-Garcia H., Romero-Garcia S., Valencia-Camargo A.D., Alvarez-Pulido A.2019Frontiers in OncologyWoS-id: 000497964700001
Scopus-id: 2-s2.0-85074478732
2120
26Synergistic antitumorigenic activity of calcitriol with curcumin or resveratrol is mediated by angiogenesis inhibition in triple negative breast cancer xenograftsCoautor: Prado-Garcia, Heriberto, Garcia-Quiroz, Janice, Garcia-Becerra, Rocio, Santos-Cuevas, Clara, et al.2019CancersWoS-id: 000502290100121
Scopus-id: 2-s2.0-85074979868
4951
27The PD-L1/PD-1 pathway promotes dysfunction, but not ?exhaustion?, in tumor-responding T cells from pleural effusions in lung cancer patients1ᵉʳ autor: Prado-Garcia H., Romero-Garcia S., Puerto-Aquino A., Rumbo-Nava U.2017CANCER IMMUNOLOGY IMMUNOTHERAPYWoS-id: 000402133900008
Scopus-id: 2-s2.0-85015044182
3742
28Lactate contribution to the tumor microenvironment: Mechanisms, effects on immune cells and therapeutic relevanceCoautor: Prado-Garcia H., Romero-Garcia S., Moreno-Altamirano M.M.B., Sánchez-García F.J.2016FRONTIERS IN IMMUNOLOGYWoS-id: 000370124800002
Scopus-id: 2-s2.0-84962526021
372395
29In Vivo Chemoprotective Activity of Bovine Dialyzable Leukocyte Extract in Mouse Bone Marrow Cells against Damage Induced by 5-FluorouracilCoautor: Prado-García H., Coronado-Cerda E.E., Franco-Molina M.A., Mendoza-Gamboa E., et al.2016JOURNAL OF IMMUNOLOGY RESEARCHWoS-id: 000375262200001
Scopus-id: 2-s2.0-84971517347
1720
30Antihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo studyCoautor: Prado-Garcia H., Segovia-Mendoza M., Jurado R., Mir R., et al.2015Bmc CancerWoS-id: 000348813200003
Scopus-id: 2-s2.0-84938868262
2729
31Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cellsCoautor: PradoGarcia, H, SegoviaMendoza, M, Diaz, L, GonzalezGonzalez, ME, et al.2015JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGYWoS-id: 000351786200019
Scopus-id: 2-s2.0-84925535810
4349
32Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile1ᵉʳ autor: Prado-Garcia H., Romero-Garcia S., Rumbo-Nava U., Lopez-Gonzalez J.S.2015ANTICANCER RESEARCHWoS-id: 000352462900039
Scopus-id: 2-s2.0-84924943736
1316
33LAP TGF-Beta Subset of CD4(+)CD25(+)CD127(-) Treg Cells is Increased and Overexpresses LAP TGF-Beta in Lung Adenocarcinoma Patients2ᵒ autor: Prado-Garcia H., Islas-Vazquez L., Aguilar-Cazares D., Meneses-Flores M., et al.2015BIOMED RESEARCH INTERNATIONALWoS-id: 000364656600001
Scopus-id: 2-s2.0-84947447683
2121
34Activated T Cells, but Not Lung Tumor Cells, Express Fas Ligand1ᵉʳ autor: Prado-Garcia H., Romero-Garcia S., Lopez-Gonzalez J.S.2014ANN THORAC SURGWoS-id: 000329155900083
Scopus-id: 2-s2.0-84891606367
11
35Transcriptional analysis of hnRNPA0, A1, A2, B1, and A3 in lung cancer cell lines in response to acidosis, hypoxia, and serum deprivation conditions2ᵒ autor: Prado-Garcia H., Romero-Garcia S., Lopez-Gonzalez J.S.2014EXPERIMENTAL LUNG RESEARCHWoS-id: 000329873300002
Scopus-id: 2-s2.0-84892693065
1213
36Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway1ᵉʳ autor: Prado-Garcia H., Romero-Garcia S., Morales-Fuentes J., Aguilar-Cazares D., et al.2012CANCER IMMUNOLOGY IMMUNOTHERAPYWoS-id: 000305519700011
Scopus-id: 2-s2.0-84862770457
1718
37Participation of damage-associated molecular patterns in conventional treatment of cancer [Participación de los patrones moleculares asociados al daño en el tratamiento convencional del cáncer]Coautor: Prado-García H., Rojo-León V., Aguilar-Cázares D., Carlos-Reyes A., et al.2012REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000309196300010
Scopus-id: 2-s2.0-84867179640
34
38Tumor-Induced CD8+T-Cell Dysfunction in Lung Cancer Patients1ᵉʳ autor: Prado-Garcia H., Romero-Garcia S., Aguilar-Cazares D., Meneses-Flores M., et al.2012CLINICAL & DEVELOPMENTAL IMMUNOLOGYWoS-id: 000310293000001
Scopus-id: 2-s2.0-84868704447
6673
39Tumor cell metabolism An integral viewCoautor: Prado-Garcia H., Romero-Garcia S., Lopez-Gonzalez J.S., Báez-Viveros J.L., et al.2011CANCER BIOLOGY & THERAPYWoS-id: 000298180500001
Scopus-id: 2-s2.0-82755195292
179187
40Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression1ᵉʳ autor: Prado-Garcia H., Aguilar-Cazares D., Meneses-Flores M., Morales-Fuentes J., et al.2008CANCER IMMUNOLOGY IMMUNOTHERAPYWoS-id: 000251794100005
Scopus-id: 2-s2.0-37349037860
1716
41Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-aCoautor: Prado-Garcia H., Lopez-Gonzalez J.S., Avila-Moreno F., Aguilar-Cazares D., et al.2007CLINICAL IMMUNOLOGYWoS-id: 000244430400010
Scopus-id: 2-s2.0-33846867690
1618
42Lung squamous cell carcinoma and adenocarcinoma cell lines use different mediators to induce comparable phenotypic and functional changes in human monocyte-derived dendritic cells.Coautor: Prado-García H., Avila-Moreno F., López-González J.S., Galindo-Rodríguez G., et al.2006CANCER IMMUNOLOGY IMMUNOTHERAPYWoS-id: 000235973400012
Scopus-id: 2-s2.0-33645728032
1925
43Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients1ᵉʳ autor: Prado-Garcia H., Aguilar-Cazares D., Flores-Vergara H., Mandoki J.J., et al.2005LUNG CANCERWoS-id: 000227542100008
Scopus-id: 2-s2.0-13844272823
4148
44Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines2ᵒ autor: Prado-Garcia H., Lopez-Gonzalez J.S., Aguilar-Cazares D., Molina-Guarneros J.A., et al.2004LUNG CANCERWoS-id: 000220015400004
Scopus-id: 2-s2.0-1242283943
112123
45Cytotoxic T lymphocytes in cancer and autoimmunity [Linfocitos T citotóxicos en cáncer y autoinmunidad]1ᵉʳ autor: Prado-García H., Ávila-Moreno F., López-González J.S.2004REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000226787300011
Scopus-id: 2-s2.0-12444286875
12
46Lack of correlation between growth inhibition by TGF-ß and the percentage of cells expressing type II TGF-ß receptor in human non-small cell lung carcinoma cell linesCoautor: Prado-García H., López-González J.S., Aguilar-Cázares D., Nieto-Rodríguez A., et al.2002LUNG CANCERWoS-id: 000179428500006
Scopus-id: 2-s2.0-0036838158
1718
47Alteration in the differentiation of immature human dendritic cells by lung adenocarcinomas [Alteración en la diferenciación de células dendriticas inmaduras humanas por adenocarcinomas pulmonares]Coautor: Prado García H., Ávila Moreno F., Sánchez Torres C., Rivas Carvalho A., et al.2002Revista Del Instituto Nacional De Enfermedades RespiratoriasScopus-id: 2-s2.0-18844474766
00
48Effects of cumarine and 7-hydroxicumarine on the cell cycle of pulmonary adenocarcinoma cell lines [Efecto en el ciclo celular de líneas de adenocarcinoma pulmonar por cumarina y 7-hidroxicumarina]2ᵒ autor: Prado García H., López-González J.S., Aguilar Cázares D., Molina Guarneros J.A., et al.2000Revista Del Instituto Nacional De Enfermedades RespiratoriasScopus-id: 2-s2.0-0034461454
01
Descargar PDF

Documentos no indexados (Humanindex)

Descargar PDF

Capítulos de libros (WoS y Scopus)

Descargar PDF

No se encuentran registros en la base de datos de obras con ISBN (Indautor).

Descargar PDF

No se encuentran registros en la base de datos de proyectos.

Descargar PDF

Participación en Comités de Tesis

Descargar PDF

No se encuentran registros en la base de datos de docencia impartida.

Descargar PDF

No se encuentran registros en la base de datos de patentes.

Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)